334 related articles for article (PubMed ID: 8083955)
1. Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains.
Carruth LM; Hardwick JM; Morse BA; Clements JE
J Virol; 1994 Oct; 68(10):6137-46. PubMed ID: 8083955
[TBL] [Abstract][Full Text] [Related]
2. The leucine domain of the visna virus Tat protein mediates targeting to an AP-1 site in the viral long terminal repeat.
Carruth LM; Morse BA; Clements JE
J Virol; 1996 Jul; 70(7):4338-44. PubMed ID: 8676456
[TBL] [Abstract][Full Text] [Related]
3. The visna transcriptional activator Tat: effects on the viral LTR and on cellular genes.
Neuveut C; Vigne R; Clements JE; Sire J
Virology; 1993 Nov; 197(1):236-44. PubMed ID: 8212559
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of visna virus Tat: identification of the targets for transcriptional activation and evidence for a post-transcriptional effect.
Gdovin SL; Clements JE
Virology; 1992 Jun; 188(2):438-50. PubMed ID: 1316669
[TBL] [Abstract][Full Text] [Related]
5. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR.
Ghosh S; Selby MJ; Peterlin BM
J Mol Biol; 1993 Dec; 234(3):610-9. PubMed ID: 8254663
[TBL] [Abstract][Full Text] [Related]
6. Targeting of the visna virus tat protein to AP-1 sites: interactions with the bZIP domains of fos and jun in vitro and in vivo.
Morse BA; Carruth LM; Clements JE
J Virol; 1999 Jan; 73(1):37-45. PubMed ID: 9847304
[TBL] [Abstract][Full Text] [Related]
7. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
8. Delineating minimal protein domains and promoter elements for transcriptional activation by lentivirus Tat proteins.
Southgate CD; Green MR
J Virol; 1995 Apr; 69(4):2605-10. PubMed ID: 7884911
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s).
Song CZ; Loewenstein PM; Green M
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9357-61. PubMed ID: 7937769
[TBL] [Abstract][Full Text] [Related]
10. The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.
Hardwick JM; Tse L; Applegren N; Nicholas J; Veliuona MA
J Virol; 1992 Sep; 66(9):5500-8. PubMed ID: 1323708
[TBL] [Abstract][Full Text] [Related]
11. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
Kamine J; Subramanian T; Chinnadurai G
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
[TBL] [Abstract][Full Text] [Related]
12. Identification of limiting steps for efficient trans-activation of HIV-1 promoter by Tat in Saccharomyces cerevisiae.
Daviet L; Bois F; Battisti PL; Gatignol A
J Biol Chem; 1998 Oct; 273(43):28219-28. PubMed ID: 9774443
[TBL] [Abstract][Full Text] [Related]
13. The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes.
Ohana B; Moore PA; Ruben SM; Southgate CD; Green MR; Rosen CA
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):138-42. PubMed ID: 8419915
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong transcriptional activation domain.
Yu L; Zhang Z; Loewenstein PM; Desai K; Tang Q; Mao D; Symington JS; Green M
J Virol; 1995 May; 69(5):3007-16. PubMed ID: 7707527
[TBL] [Abstract][Full Text] [Related]
15. Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment.
Xiao H; Lis JT; Jeang KT
Mol Cell Biol; 1997 Dec; 17(12):6898-905. PubMed ID: 9372921
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
17. The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function.
Venkatesh LK; Chinnadurai G
J Virol; 1993 Jul; 67(7):3868-76. PubMed ID: 8389909
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
19. Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.
Rhim H; Rice AP
Nucleic Acids Res; 1994 Oct; 22(21):4405-13. PubMed ID: 7971271
[TBL] [Abstract][Full Text] [Related]
20. The caprine arthritis encephalitis virus tat gene is dispensable for efficient viral replication in vitro and in vivo.
Harmache A; Vitu C; Russo P; Bouyac M; Hieblot C; Peveri P; Vigne R; Suzan M
J Virol; 1995 Sep; 69(9):5445-54. PubMed ID: 7636990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
